BRIVARACETAM TEVA 100mg tablets medication leaflet

N03AX23 brivaracetam • Nervous system | Antiepileptics | Other antiepileptics

Brivaracetamum is a medication used for the treatment of epilepsy, specifically focal seizures with or without secondary generalization, in patients aged 4 years and older. It is an antiepileptic drug that works by binding to the synaptic vesicle protein SV2A, reducing neuronal excitability.

The medication is administered orally or intravenously, as directed by a doctor. The dosage is adjusted based on the patient's age, weight, and response to treatment.

Common side effects include drowsiness, dizziness, fatigue, and irritability. In rare cases, more severe adverse effects such as depression or suicidal thoughts may occur, requiring close monitoring of patients.

Brivaracetamum is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.

General data about BRIVARACETAM TEVA 100mg

Substance: brivaracetam

Commercial code: W71194001

Concentration: 100mg

Pharmaceutical form: tablets

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ACTAVIS LTD. - MALTA

Holder: TEVA B.V. - TARILE DE JOS

Number: 16082/2025/01

Shelf life: 2 years

Pharmaceutical forms available for brivaracetam

Concentrations available for brivaracetam

100mg, 10mg, 10mg/ml, 25mg, 50mg, 75mg